Search Results

Study Evaluates IVUS for Detecting Dissections in Femoropopliteal Vessels After PTA

July 11, 2018—Nicolas W. Shammas, MD, et al published results from the iDissection classification study in Journal of Invasive Cardiology (2018;30:240–244).

Feasibility Study Supports Boston Scientific's JetStream XC to Treat In-Stent Restenosis

May 3, 2016—Results from the JETSTREAM-ISR feasibility study were published by Nicolas W. Shammas, MD, et al, in the Journal of Endovascular Therapy (JEVT; 2016;23:339–346). The study evaluated outcomes and stent–device interaction with the JetStream XC (Boston Scientific Corporation), a rotational cutter with aspiration capacity, in treating in-stent restenosis (ISR) of the femoropopliteal segment. 

Results Published From Pivotal WISE-LE Trial of Gardia Medical's Wirion EPS in Lower Extremity Atherectomy

October 4, 2018—Results of the pivotal WISE-LE trial evaluating the Wirion embolic protection system (EPS; Gardia Medical) were published by Nicolas W. Shammas, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2018;11:1995–2003). The Primary Investigator of the WISE-LE study is Bill Gray, MD, who is with Lankenau Heart Institute in Philadelphia, Pennsylvania.

AVS’s Pulse IVL POWER PAD II Pivotal Trial Begins Enrollment

October 15, 2024—Amplitude Vascular Systems (AVS), which is focused on treating severely calcified arterial disease, announced commencement of patient enrollment in the POWER PAD II United States pivotal trial of the company’s Pulse intravascular lithotripsy (IVL) system for pulsatile intravascular lithotripsy therapy.

Intact Vascular Launches the Tack Endovascular System in the United States

May 6, 2019—Intact Vascular, Inc. announced the first commercial use of its Tack endovascular system in multiple sites across the United States.

Study Defines Optimal Tissue Debulking Protocol for Boston Scientific's Jetstream Navitus to Treat In-Stent Restenosis

February 25, 2015—Concord Biomedical Sciences & Emerging Technologies (CBSET) announced that its scientists have defined the optimal tissue debulking protocol for treating in-stent restenosis (ISR) with Boston Scientific Corporation’s Jetstream Navitus atherectomy device.

iDissection Classification Study Will Evaluate Dissection Rate of VentureMed's Flex Dynamic Scoring Catheter

November 14, 2018—VentureMed Group, Inc. recently announced the initiation of a new study to determine if the company's Flex dynamic scoring catheter reduces dissections and the need for bailout stents in peripheral arteries.

First Patients Treated With CSI’s Wirion System for Lower Extremity Embolic Protection

March 17, 2021—Cardiovascular Systems, Inc. (CSI) announced that the first patients in the United States have been treated with the company’s Wirion embolic protection system (EPS).

CSI Acquires Wirion Embolic Protection System From Gardia Medical

August 5, 2019—Cardiovascular Systems, Inc. (CSI) announced that it has acquired the Wirion embolic protection system and related assets from Gardia Medical Ltd., a wholly owned Israeli subsidiary of Allium Medical Solutions Ltd. The Wirion device is a distal embolic protection filter that is used to capture debris that can be associated with all types of peripheral vascular interventions.

Three Studies Evaluate VentureMed’s Flex Vessel Prep System

January 27, 2021—VentureMed Group, Inc. announced that data from three studies evaluating the use of the company’s Flex VP system were presented during LINC 2021, the Leipzig Interventional Course held as a virtual event January 25-29.

Findings Presented That Show Luminal Gain With VentureMed's Flex VP System

June 4, 2019—VentureMed Group, Inc. announced that new data for the company's Flex VP vessel preparation system were presented at the 20th Annual New Cardiovascular Horizons (NCVH) annual conference held May 29–31 in New Orleans, Louisiana.